| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,580,042 | 1,806,389 | 1,786,426 | 1,798,085 | | Cost of Revenue | 700,737 | 730,091 | 772,277 | 765,911 | | | Gross Profit | 879,305 | 1,076,298 | 1,014,149 | 1,032,174 | | | Operating Expenses | | Research Development | 306,043 | 278,290 | 323,172 | 314,719 | | Selling General and Administrative | 458,109 | 482,493 | 596,575 | 593,710 | | Non Recurring | 4,801 | 577,506 |
-
|
-
| | Others | 9,667 | 16,358 | 24,228 | 23,224 | | | | Total Operating Expenses | 778,620 | 1,354,647 |
-
|
-
| | | | Operating Income or Loss | 100,685 | (278,349) | 70,174 | 100,521 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,960 | 25,621 | 8,881 | 24,674 | | Earnings Before Interest And Taxes | 105,645 | (252,728) | 79,055 | 125,195 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 105,645 | (252,728) | 79,055 | 125,195 | | Income Tax Expense | 35,884 | 107,474 | 50,577 | 47,693 | | Minority Interest | 48,934 | (2,734) | (1,892) | (1,214) | | | | Net Income From Continuing Ops | 118,695 | (303,428) | 54,348 | 131,215 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 118,695 | (303,428) | 54,348 | 131,215 | | Preferred Stock And Other Adjustments | (1,137) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $117,558 | ($303,428) | $54,348 | $131,215 |
|
0.45% Nasdaq 
0.20%
Income Statement
